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Nationally representative data on urinary levels of BPA and its metabolites in the United States from the
2003–2004 to 2011–2012 National Health and Nutrition Examination Surveys (NHANES) were used to
estimate daily BPA intakes and examine temporal trends. Additionally, NHANES data on lifestyle/de-
mographic/dietary factors previously reported to be associated with BPA exposures were examined to
assess the resiliency of the reported associations (whether the association is maintained across the ﬁve
surveys). Finally, various approaches for addressing issues with the use of BPA concentration data from
spot urine samples were examined for their effect on trends and associations. Three approaches were
assessed here: (i) use of generic literature-based 24-h urine excretion volumes, (ii) use of creatinine
adjustments, and (iii) use of individual urine ﬂow rate data from NHANES. Based on 2011–2012 NHANES
urinary BPA data and assumptions described in this paper, the median daily intake for the overall po-
pulation is approximately 25 ng/kg day; median intake estimates were approximately two to three or-
ders of magnitude below current health-based guidance values. Estimates of daily BPA intake have de-
creased signiﬁcantly compared to those from the 2003–2004 NHANES. Estimates of associations between
lifestyle/demographic/dietary factors and BPA exposure revealed inconsistencies related to both NHANES
survey year and the three approaches listed above; these results demonstrate the difﬁculties in inter-
preting urinary BPA data, despite efforts to account for urine dilution and translation of spot sample data
to 24-h data. The results further underscore the importance of continued research on how to best utilize
urinary measures of environmental chemicals in exposure research. Until a consensus is achieved re-
garding the best biomonitoring approaches for assessing exposures to short-lived chemicals using urine
samples, research on factors associated with BPA exposures should include – and report results from -
assessments using both volume-based urinary BPA and creatinine-adjusted urinary BPA data.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bisphenol A (BPA, CAS no. 80-05-7) has been the subject of a
large and ever increasing number of scientiﬁc publications, with a
simple PubMed search on the term “bisphenol A” yielding almost
9000 publications; over 300 of these are review publications. Re-
search on BPA has included toxicity evaluations (reviewed ex-
tensively; see, for example, EFSA (2015), FDA (2014a) and HengstlerInc. This is an open access article u
C, 106 Oakdale Avenue, Ca-
ind),et al. (2011)), epidemiological assessments (reviewed in LaKind et al.,
2014a), toxicokinetics/toxicodynamics (Hengstler et al., 2011) and
exposure assessments (reviews for this aspect of the BPA literature
include topics such as BPA migration from polycarbonate [Hoekstra
and Simoneau, 2013] and dietary and non-dietary sources of ex-
posure [Geens et al., 2012]).
A major source of data for human exposure to BPA is the biennial
National Health and Nutrition Examination Survey (NHANES). The
US Centers for Disease Control and Prevention's (CDC) National
Center for Environmental Health provides data on urinary BPA for a
nationally representative sample of the United States (US). Five
NHANES surveys with data on BPA are now available, covering the
time period from 2003 to 2012 (Calafat et al., 2008; CDC, 2006a,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in efforts to explore temporal trends in human exposures to BPA
(e.g., LaKind et al., 2012), factors inﬂuencing human exposure (La-
Kind and Naiman, 2011; McKinney et al., 2014; Tyrrell et al., 2013)
and associations between exposure and various health outcomes
(reviewed in LaKind et al., 2014a).
During the years associated with the release of the surveys'
data (2003–2012), there has been a substantial amount of negative
media and public attention paid to general population exposures
to BPA, resulting in the introduction to the market of many “BPA-
free” products (Caliendo, 2012). In addition, the Food and Drug
Administration (FDA) no longer allows BPA-based polycarbonate
resins to be used for manufacture of baby bottles and sippy cups
(FDA, 2014b) and 11 states no longer permit use of BPA in infant
feeding containers (http://www.consumerreports.org/cro/news/
2011/10/california-joins-10-other-states-in-banning-bpa-from-in
fant-feeding-containers/index.htm). It is therefore possible that
overall background human exposure to BPA has declined since
2003. While NHANES data cannot be used to examine the effect of
the FDA action (urinary BPA data are not collected for children
under six years of age), the general potential impact of public
awareness on BPA exposures may be observable. If a decline is
observed, it may be possible to use factors reported to be asso-
ciated with urinary BPA levels to better understand which seg-
ments of the overall population are experiencing those decreases
and why.
Various lifestyle, demographic and dietary factors have been
reported to be associated with urinary BPA concentrations, in-
cluding tobacco smoke exposure (Braun et al., 2011; Geens et al.,
2014), family educational level (Covaci et al., 2015), canned foods
(Covaci et al., 2015), household income (Geens et al., 2014; LaKind
and Naiman, 2011), race/ethnicity, consumption of soda, school
lunches and meals not prepared at home, and age and gender
(LaKind and Naiman, 2011). Data on various demographic and
lifestyle factors are available from NHANES. However, while the
NHANES database includes information on aspects of the US po-
pulation's diet (considered to be the major contributor to BPA
exposure), due to the rapid metabolism and excretion of BPA, only
those data capturing exposures occurring within the approxi-
mately 24-h prior to urine sample collection are relevant to such
an exploration. This limits the NHANES dietary assessments to
only a few food/drink items (LaKind and Naiman, 2011).
Because the urine samples used to measure urinary BPA are spot
samples – as opposed to 24-h samples – it is generally recognized
that a method is needed for addressing the variation associated with
effect of urine dilution on the volume-based BPA concentrations. The
most common method is to adjust the urinary volume measure (ng
BPA/ml urine) with urinary creatinine concentrations (Barr et al.,
2005), which are also reported in the NHANES datasets. However,
this introduces complications to the interpretation of results of
NHANES-based research which are not yet fully understood (Chris-
tensen et al., 2014; Garde et al., 2004; Weaver et al., 2015). Urinary
creatinine levels themselves are variable and can be affected by age,
sex, race/ethnicity, body mass index, fat-free mass, time of day of
collection of urine samples (Barr et al., 2005), exercise (Calles-Es-
candon et al., 1984), diet (Neubert and Remer, 1998) and health
(Tynkevich et al., 2014). The choice of exposure metric (e.g., un-
adjusted versus creatinine-adjusted) can introduce bias and can
modify outcomes of analyses in environmental epidemiology studies
(Christensen et al., 2014; Goodman et al., 2014). Thus, it has been
recommended that results of analyses using urinary measures of
environmental chemicals be reported for both adjusted and un-
adjusted concentrations (LaKind et al., 2014b; Weaver et al., 2015).
The urinary BPA data from spot samples can also be converted
to 24-h estimates using three different approaches. The ﬁrst is to
use generic 24-h urine excretion values to convert volume-basedurinary BPA levels (ng/ml) to daily BPA excretion (ng/day). The
second is to use generic 24-h creatinine excretion values to con-
vert creatinine-adjusted urinary BPA levels (ng/mg creatinine) to
daily BPA excretion (ng/day). For the 2009–2010 and 2011–2012
NHANES datasets, urinary ﬂow rate data are also available. Ac-
cording to the CDC, “the urine ﬂow rate is a more accurate cal-
culation used to determine urine analyte concentrations, espe-
cially exposure to environmental chemicals” (http://wwwn.cdc.
gov/nchs/nhanes/2009-2010/UCFLOW_F.htm). Thus, for two of the
NHANES surveys, urine ﬂow rate data can be used as another
approach for converting volume-based urinary BPA levels in spot
samples to daily BPA excretion.
In this paper, we explore the following questions:(1) Is there any evidence that the US population exposure to BPA
has declined during the period 2003–2012? We examine
temporal trends for urinary BPA levels (both volume-based
and creatinine-adjusted) and for daily BPA intake (ng/kg day).
Daily intakes are determined using both volume-based urinary
BPA concentrations and creatinine-adjusted BPA concentra-
tions. Finally, we compare the intake results from the 2009–
2010 and 2011–2012 NHANES data with intakes estimated
using NHANES urinary ﬂow data. By using these different
methods, we can assess whether the approaches have an effect
on the temporal trend analyses.(2) Do the ﬁve NHANES surveys provide evidence that previously-
identiﬁed lifestyle/demographic/dietary factors associated
with BPA exposures (Braun et al., 2011; Covaci et al., 2015;
Geens et al., 2014; LaKind and Naiman, 2011) are consistently
observed? We explore consistency of associations across the
ﬁve surveys using urinary BPA concentration data (volume-
based and creatinine-adjusted).2. Methods
2.1. NHANES data
The CDC's National Center for Health Statistics data ﬁles for
NHANES 2003–2004 to 2011–2012 are publicly available (CDC,
2006a, 2009, 2011a, 2011b, 2014). The BPA data (NHANES variable
URXBPH, ng/ml) are from a subsample of NHANES participants.
Total BPA, after hydrolysis of conjugated metabolites, was mea-
sured in urine samples, with the method limit of detection (LOD)
given as 0.4 ng/ml for all survey years. In the data analyses, mea-
sures below the detection limit were assigned a value of the LOD
divided by the square root of 2 (CDC, 2006a). The sample popu-
lation includes males and females ages 6 to 60þ years. The total
number of participants with urinary BPA data for the subsample in
each survey (and percent of the measurements below the LOD) is:
2003–2004 – 2517 (6.5%); 2005–2006 – 2548 (7.1%); 2007–2008 –
2604 (6.3%); 2009–2010 – 2749 (8.0%), 2011–2012 – 2489 (10.3%).
To estimate various population (and population subgroup)
quantities such as means and percentiles, weighted means and
percentiles were calculated using the NHANES two-year weights
provided by CDC (as described in the NHANES analytic guidelines
[CDC, 2006b]). The calculations of point estimates and conﬁdence
intervals were performed using R (R Core Team, 2014) with con-
ﬁdence intervals obtained using the R survey package (Lumley,
2004, 2014).
2.2. Estimating urinary BPA concentrations
We estimated both volume-based (unadjusted) and creatinine-
adjusted population metrics as recommended by LaKind et al.
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dividual's urinary BPA level (ng/ml) by their creatinine level
(NHANES variable URXUCR, mg/dL) and a unit adjustment of 0.01
to derive a creatinine-adjusted BPA concentration (mg/gr creati-
nine). No participants were excluded based on their creatinine
levels.
2.3. Estimating population BPA daily intake
Excretion of ingested BPA into urine, mainly as the glucuronide
conjugate, is essentially complete in 24 h (Dekant and Völkel,
2008; Teeguarden et al., 2011); thus, total urinary BPA (sum of the
concentrations of BPA metabolites plus the parent compound in
urine) in a 24-h urine sample approximates the BPA intake from
the previous 24 h (LaKind and Naiman, 2008). While NHANES
provides data almost exclusively for spot samples, Christensen
et al. (2012) found that spot urinary concentrations of BPA were
fairly comparable to corresponding 24-h average concentrations
obtained from a similar population indicating that “spot samples
can be used to characterize population distributions of intakes,”
with caution needed for data at the tail of the distribution. The
approach of using spot urinary BPA data to estimate daily intakes
of BPA in the US has been described previously (LaKind and Nai-
man, 2008, 2011; LaKind et al., 2012). In brief, daily BPA intake (ng/
day) was estimated by multiplying the urinary BPA concentrations
(ng/ml) by generic (ICRP, 2002) 24-h urinary output volume (ml/
day). Age- and gender-based generic values for urinary output
(ICRP, 2002) were used to create piecewise linear functions, one
for males and one for females, giving urinary output as a function
of age. These generic 24-h urinary excretion volume data are
generally consistent with other urinary output volumes in the
published literature (see LaKind and Naiman (2008) for a review of
the published literature).
Daily intakes were then adjusted for body weight (ng/kg day)
using individual body weights reported in the NHANES databases
(Eq. (1)). Individuals with missing body weight data were excluded
from the analyses.
Urinary BPA ng/ml urinary output
ml/day /body weight kg
ng BPA/kg day 1
( ) ×
( ) ( )
= − ( )
We performed parallel analyses using creatinine-adjusted ur-
inary BPA concentrations in combination with generic daily crea-
tinine excretion values (ICRP, 2002) (Eq. (2)). We used the age- and
gender-based daily creatinine excretion values (ICRP, 2002) to
create piecewise linear functions, one for males and one for fe-
males, giving creatinine output as a function of age.
Urinary BPA
, creatinine adj ng/mg creatinine creatinine output
mg/dy /body weight kg
ng BPA/kg day 2
− ( ) ×
( ) ( )
= − ( )
Using these approaches, distributions of intakes representative
of the US population were determined for (i) all participants, (ii)
participants by the following age groups: 6–11 years, 12–19 years,
20–39 years, 40–59 years, and 60þ years, (iii) participants by
gender, and (iv) participants by race/ethnicity.
Finally, daily intakes based on individual urine ﬂow rate were
determined for the more recent NHANES surveys (2009–2010 and
2011–2012) by multiplying the urinary BPA concentration (ng/ml)
for each participant by their urine averaged ﬂow rates (ml/min)
and by 1440 min/day (http://wwwn.cdc.gov/nchs/nhanes/2009-
2010/UCFLOW_F.htm; http://wwwn.cdc.gov/nchs/nhanes/2011-2012/UCFLOW_G.htm), and dividing by each participant's body
weight (Eq. (3)).
Urinary BPA ng/ml urine flow rate ml/min 1440
min/day/body weight kg
ng BPA/kg day 3
( ) × ( ) ×
( )
= − ( )
2.4. Associations between lifestyle/demographic/dietary factors and
urinary BPA concentrations or BPA daily intake
We identiﬁed lifestyle/demographic/dietary factors that were
available for at least three of the ﬁve surveys from either Labora-
tory ﬁles or from the Demographics, Examination, and Ques-
tionnaire ﬁles. For exposure via ingestion, two questions were
speciﬁcally related to consumption of packaged food/drink that
also focused on recent exposures (thus addressing the issue of
BPA's short physiologic half-life): school lunches and meals ob-
tained from outside the home. Information on demographics and
smoking were also available for multiple NHANES surveys. The
NHANES variable names, ages for which data were collected, and
URLs for this information are given in Table 1. For education,
analyses were conducted for adults only because for younger in-
dividuals school level is roughly a proxy for age.
In order to determine whether there is an association between
BPA concentration and a predictor variable of interest, we ﬁt re-
gression models with log urinary BPA or log creatinine-adjusted
urinary BPA as the response variable, taking into account the
complex survey design, and tested for signiﬁcant associations
using the estimated regression coefﬁcients and their standard er-
rors. We also examined associations with BPA daily intakes as the
response variable, using the three methods described above: in-
takes estimated with generic (ICRP, 2002) values for 24-h urinary
excretion; intake based on creatinine-adjusted urinary BPA, and
BPA concentrations adjusted for individual urine ﬂow rate (for
NHANES 2009–2010 and 2011–2012 survey data only). All of the
calculations were carried out in R using the survey package
(Lumley, 2004, 2014; R Core Team, 2014). Identical results were
obtained using Stata 13, using the svy preﬁx for the regress
command (StataCorp, 2013).
Predictor variables can be taken to be categorical or continuous.
The categorical variables are: gender, ethnicity, and smoking sta-
tus. The continuous variables are: numbers of school lunches,
numbers of meals prepared away from home, income, age, edu-
cation level, and number of cigarettes in the past 5 days.
In some cases, a continuous predictor variable was found to be
considerably skewed (meals prepared away from home and number
of cigarettes smoked). For these cases, regression models were also
ﬁt using log-transformations of the predictor variable. These trans-
formations did not change the results in any substantial way (results
not shown).
The above tests of association refer to individual two-year
surveys. We are also interested in whether evidence of association
between BPA and a particular dietary, lifestyle, or demographic
factor emerges when tests over multiple surveys are combined.
For the purpose of pooling over multiple surveys, we report what
we refer to as an overall p-value for testing the null hypothesis of
no association over all available surveys against the alternative of
association over some of the available surveys using Fisher's
method for combining independent p-values (Fisher, 1925). Here,
if p-values p p, ... , n1 are obtained in n independent surveys, then
an overall p-value is given by the tail probability for the
2χ distribution with 2n degrees of freedom at the value:
Table 1
NHANES variables used to examine associations with urinary BPA, variable names, age ranges for available data, and URL.
Variable NHANES variable name Data age range URL
Demographics:
Age (years) RIDAGEYR 0 yearsþ http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/DEMO_c.htm
Education DMDEDUC2 20 yearsþ http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/DEMO_D.htm
Gender RIAGENDR 0 yearsþ http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/demo_e.htm
Household income INDHHINC 0 yearsþ http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/DEMO_F.htm
Ethnicity RIDRETH1 0 yearsþ http://wwwn.cdc.gov/nchs/nhanes/2011-2012/DEMO_G.htm
Food:
Meals away from homea DBD091 or DBD895 1 yearsþ http://wwwn.cdc.gov/nchs/nhanes/2005-2006/DBQ_D.htm
http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/DBQ_E.htm
http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/DBQ_F.htm
School lunchesb DBD381 1 yearsþ
Smoking: SMQ040 20 yearsþ http://wwwn.cdc.gov/nchs/nhanes/2003-2004/SMQ_C.htm
Do you now smoke http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/SMQ_D.htm
cigarettes? Every day, http://wwwn.cdc.gov/nchs/nhanes/2007-2008/SMQ_E.htm
some days, not at all http://wwwn.cdc.gov/nchs/nhanes/2009-2010/SMQ_F.htm
http://wwwn.cdc.gov/nchs/nhanes/2011-2012/SMQ_G.htm
Number of cigarettes SMQ720 12 yearsþ http://wwwn.cdc.gov/nchs/nhanes/2003-2004/SMQMEC_C.htm
smoked per day, past 5 http://wwwn.cdc.gov/nchs/nhanes/2005-2006/SMQRTU_D.htm
days http://wwwn.cdc.gov/nchs/nhanes/2007-2008/SMQRTU_E.htm
http://wwwn.cdc.gov/nchs/nhanes/2009-2010/SMQRTU_F.htm
http://wwwn.cdc.gov/nchs/nhanes/2011-2012/SMQRTU_G.htm
a The language for the variable for meals away from home for the 2005–2006 survey (DBD091-# of times/week eat meals not from a home) was modiﬁed slightly for
2007–2008 and 2009–2010 (DBD895 – number of meals not home prepared).
b # times/week get school lunch.
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3. Results
3.1. Temporal trends in BPA exposure in the US from 2003–2012
Urinary BPA: Percentiles and means of the NHANES urinary BPA
data (unadjusted and creatinine-adjusted) for surveys from 2003
to 2010 have been reported by CDC (http://www.cdc.gov/ex
posurereport/) and published elsewhere (LaKind and Naiman,
2008, 2011; LaKind et al., 2012). Descriptive information for the
2011–2012 survey data is given in Table 2.
Geometric mean urinary BPA levels for the overall US popula-
tion declined signiﬁcantly from 2.64 ng/ml (95% CIs: 2.38, 2.94)
(http://www.cdc.gov/exposurereport/pdf/FourthReport_Updated
Tables_Sep2013.pdf) in 2003–2004 to 1.5 ng/ml (95% CIs 1.4, 1.6) in
2011–2012. A similar trend was observed for creatinine-adjusted
urinary BPA measures with overall levels signiﬁcantly declining
from 2003–2004 (GM; 95% CI: 2.5; 2.3–2.7 mg/g creatinine) to
2011–2012 (GM; 95% CI: 1.66; 1.56–1.76 mg/g creatinine). In addi-
tion, from the 2003–2004 survey to the 2011–2012 survey, the
percentage of BPA measures below the detection limit increased
from 6.5% to 10.3%.
BPA Daily Intake: Percentiles and means were estimated for BPA
daily intakes for the ﬁve NHANES surveys based on individual ur-
inary BPA data and individual body weight data as described in the
previous section. Intakes for 2003–2010 have been published pre-
viously (LaKind and Naiman, 2008, 2011; LaKind et al., 2012). Table 3
gives results for 2011–2012 by total population, age group, gender
and race/ethnicity. For 2011–2012, median BPA intakes were higher
for males than females. Median BPA intakes were similar across age
groups; the highest intakes were for the 6–11 and 12–19 years age
groups, but these intakes did not differ signiﬁcantly from the other
age groups. These age-related intake differences are generally con-
sistent with those noted for the 2003–2004 and 2005–2006
NHANES surveys reported by LaKind and Naiman (2008, 2011). Forthe 2007–2008 NHANES survey, the highest intakes were in the
12–19 year age group.
Adjusting for creatinine, 40–59 year olds in the 2011–2012
survey had higher intakes compared to other adults and adoles-
cents (Table 3), although the difference was not signiﬁcant. Intakes
for males are higher than for females, but the difference was not
signiﬁcant.
While intake estimates using NHANES urinary ﬂow rate data
cannot be used to examine temporal trends (as these data are only
available for 2009–2010 and 2011–2012), they can be used to
evaluate whether this approach yields intake estimates that vary
widely from the generic-based and creatinine-adjusted estimates.
Table 3 shows median intakes for 2011–2012 estimated from the
individual ﬂow rate data; use of individual urine ﬂow rate data
does not have a signiﬁcant impact on estimates of median popu-
lation intake as compared to the two other approaches for esti-
mating daily intake.
Median BPA intakes and 95% CIs for the overall US population
from 2003–2004 through 2011–2012 NHANES surveys are shown
in Fig. 1. Over this time period, there has been an observable de-
cline in BPA intakes for both unadjusted and creatinine-adjusted
concentrations. While differences between adjacent surveys are
generally not statistically signiﬁcantly different (with an exception
being from 2003–2004 to 2005–2006), across the overall time
period the decline has been signiﬁcant.
3.2. Associations between urinary BPA and lifestyle/demographic/
dietary factors
The results of the assessment of associations between NHANES
lifestyle/demographic/dietary factors and urinary BPA data are
described here and summarized in Table 4. If a variable was not
examined for a given survey or if data have not been released,
those survey years are excluded from the tables.
3.2.1. Dietary exposure
School lunches, meals away from home: For school lunches (data
available for 2005–2006, 2007–2008, 2009–2010), the associations
were positive but only signiﬁcant for unadjusted BPA data from the
Table 2
Volume-based urinary BPA (ng/ml) and creatinine-adjusted (mg/g creatinine) BPA concentrations from the 2011–2012 NHANES survey, with additional data by age, gender, and race/ethnicity. 95% conﬁdence intervals are in
parentheses.
2011–2012: BPA (ng/ml)
All Male Female Age 6–11
year
Age 12–19
year
Age 20–39
year
Age 40–59
year
Age 60þyear Mexican-
American
Other-Hispanic Non-Hispanic
Black
Non-Hispanic
White
Other
25th %ile 0.7 (0.7,
0.8)
0.8 (0.7,
0.9)
0.6 (0.6, 0.7) 0.8 (0.6, 0.9) 0.8 (0.7, 1.0) 0.8 (0.7, 0.9) 0.7 (0.5, 0.9) 0.6 (0.5, 0.7) 0.7 (0.6, 0.8) 0.7 (0.6, 0.9) 0.7 (0.6, 0.8) 1.1 (1.0, 1.3) 0.6 (0.4, 0.7)
50th %ile 1.4 (1.3, 1.5) 1.5 (1.4, 1.7) 1.3 (1.1, 1.5) 1.5 (1.3, 1.7) 1.7 (1.3, 2.1) 1.5 (1.3, 1.7) 1.4 (1.2, 1.7) 1.2 (1.1, 1.3) 1.4 (1.2, 1.5) 1.5 (1.1, 1.9) 1.3 (1.2, 1.5) 2.1 (1.9, 2.4) 1.1 (1.0, 1.4)
75th %ile 3.0 (2.7,
3.3)
3.2 (2.7,
3.7)
2.8 (2.4, 3.2) 3.1 (2.7, 3.5) 3.3 (2.9, 4.0) 2.9 (2.5, 3.4) 3.1 (2.7, 3.5) 2.6 (2.0, 3.1) 2.8 (2.4, 3.0) 2.7 (1.9, 5.1) 2.9 (2.6, 3.2) 4.1 (3.5, 4.6) 2.3 (1.8, 3.1)
95th %ile 9.4 (7.8,
11.2)
9.5 (8.1,
11.6)
8.5 (7.1, 13.3) 8.5 (7.0,
40.6)
9.9 (7.8, 13.4) 10.6 (8.0,
14.9)
9.6 (6.5, 14.0) 7.4 (5.4, 14.0) 7.6 (6.5, 9.6) 10.4 (6.7, 74.7) 8.9 (7.3, 13.6) 11.3 (8.4, 14.7) 7.4 (4.9, 17.3)
Mean 3.3 (2.8,
3.7)
3.6 (2.9,
4.4)
2.9 (2.2, 3.6) 3.6 (2.4, 4.8) 3.3 (2.3, 4.3) 3.0 (2.6, 3.4) 3.6 (2.0, 5.2) 2.9 (1.6, 4.2) 3.0 (1.9, 4.2) 2.8 (1.5, 4.1) 3.3 (2.4, 4.1) 3.9 (3.3, 4.5) 2.7 (1.8, 3.6)
GM 1.5 (1.4, 1.6) 1.6 (1.5, 1.8) 1.4 (1.3, 1.5) 1.6 (1.4, 1.8) 1.7 (1.4, 2.0) 1.6 (1.4, 1.8) 1.5 (1.3, 1.7) 1.3 (1.2, 1.5) 1.4 (1.3, 1.6) 1.5 (1.1, 2.1) 1.5 (1.4, 1.6) 2.1 (1.9, 2.4) 1.2 (1.1, 1.4)
Count 2489 1259 1230 396 388 623 553 529 310 235 813 661 418
2011–2012: BPA (mg/g creatinine)
All Male Female Age 6–11
year
Age 12–19
year
Age 20–39
year
Age 40–59
year
Age 60þyear Mexican-
American
Other-Hispanic Non-Hispanic
Black
Non-Hispanic
White
Other
25th %ile 1.0 (0.9, 1.0) 0.8 (0.8,
0.9)
1.1 (1.0, 1.2) 1.3 (1.1, 1.4) 0.9 (0.8, 1.0) 1.0 (0.9, 1.0) 0.9 (0.8, 1.1) 0.9 (0.8, 1.0) 0.9 (0.9, 1.0) 1.0 (0.7, 1.2) 1.0 (0.9, 1.1) 1.0 (0.9, 1.1) 0.8 (0.7, 1.0)
50th %ile 1.6 (1.5, 1.7) 1.4 (1.2, 1.6) 1.8 (1.6, 2.0) 2.0 (1.8, 2.1) 1.5 (1.2, 1.9) 1.5 (1.3, 1.6) 1.7 (1.4, 1.9) 1.6 (1.4, 1.8) 1.5 (1.3, 1.6) 1.5 (1.2, 1.9) 1.6 (1.5, 1.8) 1.5 (1.3, 1.7) 1.5 (1.3, 1.7)
75th %ile 2.9 (2.7,
3.0)
2.6 (2.2,
2.9)
2.9 (2.8, 3.2) 3.3 (3.0, 3.8) 2.9 (2.3, 3.2) 2.6 (2.0, 2.9) 2.9 (2.7, 3.0) 2.9 (2.4, 3.3) 2.7 (2.4, 3.0) 2.9 (1.9, 4.2) 2.9 (2.7, 3.1) 2.6 (2.2, 3.1) 2.7 (2.1, 3.1)
95th %ile 8.2 (6.8,
11.0)
8.2 (6.5,
11.1)
8.1 (6.3, 11.3) 14.0 (8.3,
49.0)
8.3 (4.4,
89.9)
9.1 (5.6, 14.6) 7.7 (5.4, 20.3) 6.5 (5.3, 12.5) 7.2 (5.1,11.5) 8.0 (5.4, 62.2) 8.9 (6.5, 12.4) 7.2 (6.2, 10.8) 7.9 (5.0, 14.6)
Mean 3.0 (2.5,
3.6)
2.7 (2.4,
3.1)
3.3 (2.3, 4.3) 4.2 (3.0, 5.4) 2.7 (2.0, 3.3) 2.5 (2.1, 3.0) 3.5 (2.2, 4.8) 2.8 (2.0, 3.5) 2.6 (2.0, 3.1) 2.7 (1.5, 3.8) 3.0 (2.6, 3.5) 2.6 (2.2, 2.9) 5.1 (0.5, 9.6)
GM 1.7 (1.6, 1.8) 1.5 (1.4, 1.7) 1.9 (1.8, 2.1) 2.3 (2.0, 2.6) 1.6 (1.5, 1.9) 1.6 (1.5, 1.8) 1.7 (1.6, 1.9) 1.7 (1.5, 1.9) 1.6 (1.5, 1.8) 1.7 (1.3, 2.2) 1.8 (1.7, 1.9) 1.7 (1.5, 1.8) 1.6 (1.4, 1.8)
Count 2487 1258 1229 395 388 622 553 529 310 235 811 661 418
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Table 3
BPA intakes (ng/kg day) in the US based on urinary BPA and creatinine-adjusted BPA concentrations from the 2011–2012 NHANES survey, with additional data by age, gender and race/ethnicity. 95% conﬁdence intervals are in
parentheses.
2011–2012: generic volume-based BPA intake (ng/kg day)
All Male Female Age 6–11
year
Age 12–19
year
Age 20–39
year
Age 40–59
year
Age 60þ Mexican-
American
Other-Hispanic Non-Hispanic
Black
Non-Hispanic
White
Other
25th %ile 12.4 (11.6,
13.6)
14.4 (12.7,
16.9)
11.3 (9.7, 12.3) 13.9 (9.9,
16.7)
13.3 (11.3,
17.0)
13.8 (11.7,
16.4)
11.7 (9.5,
14.8)
11.0 (9.3,
12.2)
12.8 (10.9, 15.2) 14.2 (10.8, 16.2) 11.7 (10.9, 12.9) 16.7 (14.7, 18.7) 11.6 (9.4, 14.1)
50th %ile 24.9 (23.6,
27.3)
27.8 (25.3,
31.8)
22.1 (19.2,
25.0)
30.5 (23.4,
34.6)
30.8 (25.3,
37.6)
25.8 (23.5,
30.3)
23.7 (20.7,
27.8)
23.6 (18.6,
26.2)
25.3 (22.4, 30.3) 26.5 (19.4, 32.1) 24.3 (22.2, 25.8) 33.1 (29.8, 38.8) 21.7 (20.1,
25.0)
75th %ile 51.7 (47.8,
59.7)
59.5 (50.5,
67.4)
47.5 (40.9,
52.7)
56.8 (51.0,
67.2)
62.2 (52.0,
77.7)
50.6 (46.1,
60.3)
50.3 (45.6,
62.2)
45.2 (36.9,
54.8)
51.0 (42.9, 62.2) 49.7 (32.1, 111) 50.9 (46.1, 58.6) 67.8 (57.1, 77.2) 44.6 (35.8,
59.4)
95th %ile 165 (150,
205)
182 (158,
206)
160 (132,
208)
197 (148,
443)
221 (146,
277)
189 (146,
256)
156 (110,
208)
141 (105,
238)
145 (116, 216) 186 (126, 430) 162 (143, 208) 208 (168, 244) 160 (94.8,
484)
Mean 59.3 (49.7,
68.9)
71.5 (54.2,
88.8)
47.5 (38.1,
57.0)
67.4 (49.6,
85.3)
68.3 (42.7,
93.9)
53.4 (45.4,
61.3)
65.5 (27.0,
104)
49.5 (31.8,
67.3)
61.0 (26.6, 95.4) 55.0 (31.3, 78.8) 58.9 (40.5, 77.4) 65.7 (53.7, 77.7) 56.6 (34.2,
79.0)
GM 26.8 (25.1,
28.6)
30.5 (27.8,
33.5)
23.6 (21.4,
26.1)
30.4 (27.0,
34.2)
31.0 (26.0,
36.9)
28.0 (25.3,
31.1)
25.4 (21.6,
29.8)
23.6 (20.9,
26.8)
26.6 (23.5, 30.2) 27.9 (20.5, 38.0) 25.7 (23.9, 27.7) 34.2 (29.7, 39.2) 24.4 (20.8,
28.7)
Count 2460 1248 1212 395 384 616 544 521 305 234 801 656 405
2011–2012: creatinine-adjusted BPA intake (ng/kg day)
All Male Female Age 6–11 Age 12–19 Age 20–39 Age 40–59 Age 60þ Mexican-
American
Other-Hispanic Non-Hispanic
Black
Non-Hispanic
White
Other
25th %ile 15.0 (13.9,
16.0)
15.4 (14.0,
17.4)
14.3 (13.1,
15.8)
18.7 (16.2,
20.4)
14.1 (12.6,
16.4)
15.5 (13.8,
16.9)
14.1 (11.4,
17.1)
14.8 (13.4,
16.4)
15.2 (13.1, 17.4) 15.5 (12.5, 19.2) 15.0 (13.7, 16.9) 13.8 (11.9, 15.0) 14.5 (11.9,
18.2)
50th %ile 26.1 (24.3,
27.9)
27.3 (24.3,
30.3)
25.0 (22.8,
27.8)
34.0 (29.9,
37.9)
26.1 (20.9,
33.6)
24.3 (23.1,
25.7)
27.1 (22.8,
29.8)
25.0 (22.0,
28.9)
26.2 (23.3, 29.0) 24.7 (19.3, 34.4) 26.8 (24.4, 29.3) 21.9 (19.4, 25.7) 27.7 (23.2,
30.8)
75th %ile 48.0 (43.7,
53.3)
52.3 (44.1,
58.1)
45.8 (41.4,
52.7)
61.6 (52.3,
72.7)
51.8 (43.3,
64.8)
41.2 (37.7,
44.3)
49.0 (40.5,
57.4)
54.7 (42.9,
58.6)
47.7 (39.7, 56.5) 46.3 (37.7, 68.5) 50.8 (45.6, 56.2) 42.0 (34.3, 50.9) 47.0 (37.1,
61.7)
95th %ile 151 (111, 187) 167 (140,
203)
118 (96.9,
170)
240 (149,
577)
183 (105,
308)
150 (103,
223)
106 (91.9,
202)
112 (92.3,
238)
111 (93.4, 183) 133 (90.1,1240) 157 (110, 193) 133 (97.8, 214) 156 (90.2,
326)
Mean 48.4 (43.5,
53.2)
54.4 (48.1,
60.7)
42.6 (36.5,
48.6)
69.0 (49.8,
88.1)
53.1 (37.2,
69.0)
42.9 (36.6,
49.2)
47.8 (31.8,
63.9)
45.3 (35.9,
54.8)
48.1 (29.4, 66.7) 47.3 (27.5, 67.1) 50.0 (42.3, 57.7) 41.2 (33.9, 48.5) 49.6 (35.9,
63.3)
GM 28.4 (26.7,
30.3)
29.8 (27.4,
32.5)
27.1 (24.9,
29.5)
36.9 (32.4,
42.2)
29.2 (24.9,
34.2)
27.0 (24.9,
29.4)
27.5 (24.7,
30.6)
28.2 (25.1,
31.7)
27.8 (25.3, 30.4) 28.8 (22.3, 37.2) 29.3 (27.3, 31.4) 24.7 (21.6, 28.3) 28.3 (24.4,
32.8)
Count 2458 1247 1211 394 384 615 544 521 305 234 799 656 405
2011–2012: urine ﬂow rate-based BPA intake (ng/kg day)
50th %ile 23.4 (22.0,
25.6)
24.7 (22.7,
27.9)
22.4 (20.7,
25.3)
35.5 (30.3,
49.1)
28.9 (24.3,
36.1)
23.7 (21.8,
27.1)
22.7 (18.9,
27.1)
17.7 (15.6,
21.5)
23.3 (21, 26.5) 23.5 (18.6, 30.5) 23 (21.5, 25.9) 24.3 (22.0, 29.1) 22.9 (18.2,
29.6)
Count 2316 1174 1142 337 358 599 520 502 289 218 771 607 375
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Fig. 1. Median BPA intakes (ng/kg day) and 95% CIs for the overall US population from 2003–2004 through 2011–2012 NHANES surveys. Blue¼ intakes based on unadjusted
concentrations; Red¼ intakes based on creatinine-adjusted concentrations.
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and .31 for adjusted BPA, consistent with the results from individual
surveys. Meals away from home were consistently positively and
signiﬁcantly associated with urinary BPA levels across surveys (data
were available for 2005–2006, 2007–2008, 2009–2010) (the overall
p-value was .00017). However, when urinary BPA was creatinine-
adjusted, the results were no longer signiﬁcant for any survey year
(overall p-value of .71).
3.2.2. Lifestyle/demographic factors
Income: Income was consistently inversely associated with
urinary BPA (both adjusted and unadjusted). The results reached
signiﬁcance only for 2003–2004, 2005–2006 and 2011–2012 (the
overall p-values were 5.4105 for unadjusted BPA and 2104
for creatinine-adjusted BPA).
Age: Age was consistently signiﬁcantly negatively correlated
(po .05) with unadjusted urinary BPA across all ﬁve surveys.
However, after adjusting BPA with creatinine, the direction of the
correlation became inconsistent across surveys and the results
were no longer signiﬁcant (2009–2010 borderline signiﬁcant). This
is consistent with the overall p-value o .00001 for unadjusted BPA
and .17 for creatinine-adjusted BPA.
Race/ethnicity: Using non-Hispanic Whites as the reference
group, only Blacks had consistently signiﬁcantly higher urinary
BPA levels across surveys (po .001) for unadjusted urinary BPA;
the results were no longer signiﬁcant when creatinine-adjusted
BPA levels were used and the direction of association was reversed
for four of the ﬁve surveys. Mexican-Americans had higher urinary
BPA levels compared to non-Hispanic Whites across all surveys for
unadjusted BPA but results did not achieve signiﬁcance; the di-
rection of the association changed after creatinine adjustment.
Hispanics also had higher urinary BPA levels compared to non-
Hispanic Whites across surveys but results were statistically sig-
niﬁcant only for 2009–2010; results were all non-signiﬁcant after
adjusting for creatinine. The overall p-values for Black/non-His-
panic White difference are o .00001 for unadjusted BPA and .04
for creatinine-adjusted BPA.
Gender: For unadjusted urinary BPA, males had higher levels
compared to females across all surveys and results were signiﬁcant
(borderline signiﬁcant for 2011–2012). However, when analyses
were conducted using creatinine-adjusted BPA, the opposite re-
sults were obtained: females had consistently signiﬁcantly higher
levels of BPA than males (overall p-value of .000024 for unadjusted
BPA and o .00001 for adjusted BPA).
Education: For four of the ﬁve survey years, education was
inversely associated with urinary BPA (both unadjusted and ad-
justed) but results were generally not signiﬁcant. However, the
overall p-value was .02 for unadjusted BPA; the p-value was .55 forcreatinine-adjusted BPA.
Smoking: Associations between smoking and urinary BPA were
assessed using two different smoking-related questions: does the
participant smoke cigarettes now (with responses including every
day, some days, or not at all) and number of cigarettes smoked
over the previous ﬁve days. For the ﬁrst question, using un-
adjusted urinary BPA, a positive association was observed for all
survey years for those who reported smoking every day, compared
to those who responded “not at all;” however, none of the results
reached the level of signiﬁcance. Yet the overall p-value for the test
of association for daily smokers is .04 for unadjusted BPA. In
contrast, when using creatinine-adjusted BPA levels in the ana-
lyses, for 2009–2010 the direction of the associations was in-
dicative of a small but insigniﬁcant negative association while for
2003–2004, 2007–2008 and 2011–2012, a positive signiﬁcant as-
sociation (po .05) was observed. The overall p-value for creati-
nine-adjusted BPA for daily smokers is .002.
For associations between number of cigarettes smoked in the
past ﬁve days and either unadjusted or adjusted urinary BPA le-
vels, the direction of the association was inconsistent across sur-
veys and results did not reach signiﬁcance.
We also conducted analyses of associations between BPA daily
intake based on (i) the generic (ICRP, 2002) 24-h urine excretion
volumes, (ii) generic (ICRP, 2002) 24-h creatinine excretion data, and
(iii) 24-h urine excretion volumes for each individual from the
NHANES urine ﬂow rate data (2009–2010 and 2011–2012 only) and
the same lifestyle/demographic/dietary variables given in Table 4
(results not shown). In general, as with the approach of using urinary
BPA measures, we found various inconsistencies across methods.4. Discussion
In this paper, we used the ﬁve NHANES surveys with urinary BPA
levels to assess whether temporal trends in US population exposures
were discernable. We further used these data to evaluate whether
lifestyle/demographic/dietary factors previously reported to be as-
sociated with urinary BPA levels were consistently observed for the
ﬁve surveys. We recognize that NHANES is a cross-sectional study
and measured urinary BPA levels only reﬂect very recent exposures.
We therefore were careful in our analyses of lifestyle/dietary asso-
ciation assessments to include only those NHANES variables that
could be plausibly associated with exposures occurring within the
previous 24-h period. Here, we discuss temporal trends, associa-
tions, and approaches for addressing issues stemming from the use
of spot urine samples in these types of analyses.
Table 4
Associations between urinary BPA concentrations and lifestyle/demographic/dietary factors in the 2003–2012 NHANES data. Results are shown for both unadjusted urinary
BPA and creatinine-adjusted urinary BPA. Coefﬁcients (β), p-values and N are given. Signiﬁcance (bolded) is at po .05. Coefﬁcients and p values are for log-transformed BPA.
School lunches
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – Na
Y05-06 0.007 0.86 0.027 0.46 – – – – 521
Y07-08 0.031 0.47 0.04 0.23 – – – – 304
Y09-10 0.093 0.02 0.038 0.26 – – – – 318
Meals away
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y05-06 0.02 0.02 0.004 0.56 – – – – 2168
Y07-08 0.03 0.003 0.003 0.67 – – – – 2201
Y09-10 0.02 0.02 0.006 0.41 – – – – 2322
Income
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y03-04 0.048 0.008 0.035 0.005 – – – – 1392
Y05-06 0.029 0.03 0.023 0.03 – – – – 2066
Y07-08 0.018 0.11 0.019 0.05 – – – – 2045
Y09-10 0.017 0.05 0.009 0.34 – – – – 2079
Y11-12 0.035 0.008 0.024 0.02 – – – – 1872
Age
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y03-04 0.01 9.00E05 0.001 0.12 – – – – 1488
Y05-06 0.01 o00001 0.001 0.25 – – – – 2192
Y07-08 0.01 o00001 0.0002 0.87 – – – – 2215
Y09-10 0.005 0.008 0.002 0.05 – – – – 2334
Y11-12 0.005 0.02 0.001 0.65 – – – – 2093
Race/ethnicity (unadjusted for creatinine; non-Hispanic White as reference)
Mexican American Black Other Hispanic N
β p-Value β p-Value β p-Value β p-Value
Y03-04 0.106 0.23 0.575 7E05 0.394 0.01 0.023 0.91 1488
Y05-06 0.194 0.08 0.366 0.0003 0.080 0.60 0.375 0.08 2192
Y07-08 0.045 0.45 0.272 0.001 0.361 0.03 0.031 0.77 2215
Y09-10 0.108 0.12 0.377 0.0002 0.189 0.43 0.322 0.001 2334
Y11-12 0.034 0.57 0.366 8E05 0.192 0.03 0.048 0.76 2093
Race/ethnicity (creatinine-adjusted, non-Hispanic White as reference)
Mexican American Black Other Hispanic N
β p-Value β p-Value β p-Value β p-Value
Y03-04 0.103 0.11 0.108 0.19 0.282 0.05 0.091 0.60 1487
Y05-06 0.010 0.89 0.063 0.15 0.014 0.92 0.102 0.49 2192
Y07-08 0.054 0.31 0.063 0.27 0.177 0.12 0.064 0.46 2215
Y09-10 0.047 0.39 0.096 0.09 0.137 0.41 0.033 0.58 2334
Y11-12 0.092 0.07 0.0945 0.11 0.167 0.03 0.051 0.72 2092
Gender (female as reference)
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y03-04 0.186 0.01 0.186 0.01 – – – – 1488
Y05-06 0.187 0.03 0.212 0.0002 – – – – 2192
Y07-08 0.097 0.01 0.263 o00001 – – – – 2215
Y09-10 0.099 0.01 0.212 5E-05 – – – – 2334
Y11-12 0.152 0.06 0.266 0.0004 – – – – 2093
Education (adults)
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y03-04 0.068 0.04 0.002 0.95 – – – – 1488
Y05-06 0.070 0.05 0.022 0.37 – – – – 1490
Y07-08 0.009 0.73 0.001 0.96 – – – – 1814
Y09-10 0.016 0.54 0.032 0.21 – – – – 1914
Y11-12 0.067 0.03 0.031 0.17 – – – – 1705
Smokingb
β (smokes daily –
unadjusted)
p-Value (smokes daily –
unadjusted)
β (smokes daily –
adjusted)
p-Value (smokes daily –
adjusted)
Nc
Y03-04 0.132 0.13 0.159 0.03 – – – – 744
Y05-06 0.155 0.14 0.105 0.31 – – – – 690
Y07-08 0.120 0.13 0.138 0.006 – – – – 857
Y09-10 0.124 0.12 0.002 0.97 – – – – 918
Y11-12 0.125 0.29 0.138 0.02 – – – – 723
Number of cigarettes smoked in past 5 daysd
β (unadjusted) p-Value (unadjusted) β (adjusted) p-Value (adjusted) – – – – N
Y03-04 0.001 0.88 0.007 0.21 – – – – 309
Y05-06 0.01 0.28 0.005 0.34 – – – – 391
Y07-08 0.003 0.53 0.001 0.75 – – – – 427
Y09-10 0.011 0.05 0.003 0.44 – – – – 429
Y11-12 0.003 0.72 0.008 0.05 – – – – 355
–¼not relevant.
a N is for unadjusted BPA values. The sample size is the same for creatinine-adjusted analyses except that there was one fewer participant with relevant data for the
2003–2004 and 2011–2012 survey years.
b Participant was asked: Do you now smoke cigarettes? Possible responses include: every day, some days, not at all. Participants for this query were age 20 years and
older. The reference group for the analysis was non-smokers.
c N values for unadjusted and creatinine-adjusted analyses are the same.
d Participants were age 12 and older.
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Using the most recent NHANES data from 2011–2012 along
with the assumptions described in this paper, the median daily
intake for the overall population is now approximately 25 ng/kg
day. Fig. 1 shows the comparisons of daily median intakes of BPA
across surveys from 2003–2004 to 2011–2012. While urinary BPA
levels and BPA daily intakes from one survey period to the next
may not differ signiﬁcantly, the overall trend from 2003–2004 to
2001–2012 is downward and signiﬁcant overall.
The median daily BPA intake estimate for men is statistically
signiﬁcantly higher than for women for unadjusted urinary BPA
levels. For creatinine-adjusted levels, the median level for men
remains higher but the difference is no longer signiﬁcant. ATable 5
Geometric means (GM) for unadjusted urinary BPA, urinary creatinine, and crea-
tinine-adjusted urinary BPA for males and females and for non-Hispanic Whites
and Blacks from the 2011–2012 NHANES survey data. The ratio of geometric means
for gender in the fourth row is a ratio of ratios, i.e. 0.8¼1.1/1.47. The ratio of GMs for
race is in the lower right corner of the table, i.e. 0.9¼1.4/1.52.
GM BPA( ) GM .01 CREAT( × ) GM BPAadj( )
Male 1.6 1.07 1.5
Female 1.4 0.73 1.9
Ratio 1.1 1.47 0.8 (ratio of ratios)
Non-Hispanic White 2.1 1.26 1.7
Black 1.5 0.828 1.8
Ratio 1.4 1.52 0.9 (ratio of ratios)
Fig. 2. Comparison of daily BPA intakes for 2009–2010 NHANES using three methods:
estimated using creatinine-adjusted urinary BPA, and intakes estimated using urine ﬂow
Table 6
Comparison of 24-h urine volumes (ml/day) from the generic (ICRP, 2002) data with m
6–11 years of age 12–19 years of age
Male Female Male Female
Generic 600 600 1200 1200
2009–2010 NHANES-based mean
(median)a
1037
(744)
1052 (756) 1273 (935) 1163 (829
2011–2012 NHANES-based mean
(median)a
1251
(880)
1150 (904) 1696
(1056)
1271 (950
a Value for each participant is the mean of up to three urine ﬂow rate measuremengeneral decrease in daily BPA intake with increasing age was also
observed for unadjusted BPA intakes. However, intakes across age
groups do not differ substantially from the overall population in-
take (less than a factor of 2) and the trend was less consistent for
creatinine-adjusted BPA. For race/ethnicity, differences across
groups are relatively small and intakes are similar to the general
population (Table 3).
Existing health-based guidance values in the US and Europe can
be compared to our estimates of daily intakes. The US Environ-
mental Protection Agency (EPA, 2009) gives a value of 50 mg/kg day
(50,000 ng/kg day) as the Reference Dose (RfD) while the European
Food Safety Authority (EFSA, 2015) recently modiﬁed its Tolerable
Daily Intake (TDI) to 4 mg/kg of bw/day (4000 ng/kg day). In addition,
a provisional TDI of 25 mg/kg bw-day (25,000 ng/kg day) has been
established by Health Canada (Health Canada, 2008). Median intake
values in the US were below 35 ng/kg day for all groups analyzed (for
both unadjusted and creatinine-adjusted estimates) and the 95th
percentiles were at or below 240 ng/kg day (Table 3). Thus, median
and 95th percentile intake estimates were approximately two to three
orders of magnitude or one to two orders of magnitude below the
current health-based guidance values, respectively. This is in con-
cordance with EFSA's comparisons of highest estimates for total BPA
exposures (for example, from diet, dust, cosmetics and thermal paper)
to their new TDI (EFSA's exposure estimates were three to ﬁve times
lower than the TDI) (EFSA, 2015).
Results should be interpreted with caution due to the limitations
imposed by the underlying data and the methodology for estimating
daily intake, and especially those estimates in the tails of the intake
distributions because of the small numbers of individualsBPA intake using 24-h urine excretion from generic (ICRP, 2002) data, BPA intakes
rate-adjusted BPA concentrations. Dashed line corresponds to y¼x.
ean and median NHANES-based data by gender and age.
20–39 years of age 40–59 years of age 60þyears of age
Male Female Male Female Male Female
1600 1200 1600 1200 1600 1200
) 1928
(1326)
1511
(1004)
1669
(1201)
1424
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1381
(1086)
1250 (831)
) 1688
(1260)
1706 (1176) 1486
(1179)
1553 (1189) 1302 (996) 1564 (924)
ts.
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4.2. Associations between BPA exposure and lifestyle/demographic/
dietary characteristics
Results of assessments of associations between urinary BPA and
lifestyle/demographic/dietary factors in some cases conﬁrmed the
results of earlier studies and in other cases contradicted those
results. The ﬁve NHANES surveys therefore provide important
information on the resiliency of reported associations.
In our earlier assessment of the relationship between smoking
and urinary BPA from the 2005–2006 NHANES survey, we did not
observe a signiﬁcant association. Similarly, for all ﬁve two-year
surveys examined here, none indicate a signiﬁcant association
between unadjusted urinary BPA and smoking. However, the p-
value for the multiple test for association for daily smokers over
the ﬁve periods based on Fisher's method for combining in-
dependent p-values is .04. This suggests an association between
urinary BPA and smoking which is in accordance with some other
reports (He et al., 2009; Arbuckle et al., 2015; Geens et al., 2014). It
is not clear why the association did not hold when using number
of cigarettes smoked over the previous ﬁve days but it is possible
that smoking is a surrogate for some other type of behavior or
demographic factor which would render the number of cigarettes
smoked moot.
For the 2005–2006 survey, we reported a positive statistically
signiﬁcant association between urinary BPA and number of school
lunches per week during the school year (p¼002) and meals not
prepared at home (p¼006) (LaKind and Naiman, 2011). With ﬁve
surveys now available, we are able to examine consistency of these
associations. The results across surveys suggest that school lun-
ches are not associated with urinary BPA measures. (While we had
previously observed a signiﬁcant positive association between
school lunches and urinary BPA [LaKind and Naiman, 2011], the
method used in that analysis would have been more likely to
underestimate standard errors and p-values compared to the
method used here.) Meals consumed away from home were con-
sistently signiﬁcantly associated with urinary BPA, but only when
unadjusted urinary BPA concentrations were used in the analyses.
Creatinine-adjusted urinary measures revealed no association
with meals away from home. This underscores the importance of
reporting results for both unadjusted and creatinine-adjusted
concentrations.
In assessing BPA-lifestyle/demographic/dietary associations, one
can also use daily intakes (as opposed to urinary BPA levels). Three
methods for estimating intakes were used in this paper. These re-
sults were not uniformly consistent with those using urinary BPA as
the dependent variable; some inconsistencies across methods
(although not across surveys) may be explained by the impact of
adjusting for urinary dilution.
4.3. Adjustments for urinary dilution
Due to difﬁculties in collecting 24-h urine samples, most bio-
monitoring studies use spot samples. Spot sample data can be used
directly to provide volume-based concentrations (i.e., ng/ml BPA) or
can be adjusted by an individual's urinary creatinine level (i.e., ng
BPA/mg creatinine). While the latter approach is thought to provide
a better measure of BPA exposure by correcting for dilution, it can
also introduce complications to the interpretation of the data. In fact,
whether or not one adjusts for urinary dilution with creatinine can
have a substantial impact on assessments of associations between
lifestyle/demographic/dietary factors and BPA exposure.
For example, age was signiﬁcantly inversely associated with ur-
inary BPA concentrations, but only for unadjusted BPA levels (Table 4).
Similarly, the 2011–2012 concentration data in Table 2 reveal thatgeometric mean BPA levels are higher for men compared to women
(1.6 vs 1.4 ng/ml, respectively) when levels are not adjusted but the
reverse is true for creatinine-adjusted values (1.5 vs 1.9 mg/g creati-
nine, for men and women, respectively). Another example of the ef-
fect of creatinine-adjustment on association outcome is for race: the
2011–2012 concentration data (Table 2) reveal that geometric mean
BPA levels are higher for non-Hispanic Whites compared to Blacks
(2.1 vs 1.5 ng/ml, respectively) when levels are not adjusted but the
reverse is true for creatinine-adjusted values (1.7 vs 1.8 mg/g creati-
nine, respectively). These reversals can be explained by recalling that:
BPA
BPA
.01 CREAT
adj = ×
Consequently, the geometric means satisfy:
GM BPA
GM BPA
GM .01 CREAT
adj( ) =
( )
( × )
Focusing on the gender example, the ratio of male to female
creatinine-adjusted urinary BPA levels can be expressed as a ratio
of ratios (the lower right hand corner of Table 5):
GM BPA male
GM BPA female
GM BPAmale
GM BPA female
/
GM .01 CREATmale
GM .01 CREAT female
adj
adj
( | )
( | )
= ( | )
( | )
( × | )
( × | )
As shown in the table of geometric means (Table 5), the ratio of
geometric means for male vs. female is 1.1, which is greater than 1,
indicating that males tend to have higher BPA levels than females.
However, the ratio of geometric means for adjusted BPA levels is
0.8, which is less than 1, indicating that adjusted levels tend to be
lower for males than females. This is explained by the fact that the
ratio of creatinine geometric means (1.47) is greater than the ratio
of BPA geometric means (1.1).
This also explains why non-Hispanic Whites tend to have
higher urinary BPA levels compared to Blacks, but tend to have
lower creatinine-adjusted BPA levels (Table 5).
If as a ﬁrst approximation it is assumed that the BPA and
creatinine values are jointly bivariate log-normally distributed, the
above reasoning further explains the reversals observed for the
medians for males/females and non-Hispanic Whites/Blacks.
Consideration of the impact of urinary dilution is important
when using urinary biomonitoring data to estimate exposure
across segments of the population, but there are complications
related to creatinine adjustments that cannot be ignored. Many
studies report results for only unadjusted or only creatinine-ad-
justed urinary chemical measures. This exercise demonstrates the
importance of using and reporting on both measures (LaKind et al.,
2014b; Weaver et al., 2015).
Consideration of urinary dilution is also important when esti-
mating intakes of chemicals based on urinary biomonitoring data.
We used three different approaches to estimate daily BPA intake:
(i) generic (ICRP, 2002) 24-h urine excretion volumes, (ii) generic
(ICRP, 2002) 24 h creatinine excretion data, and (iii) 24-h urine ex-
cretion volumes for each individual using NHANES urine ﬂow rate
data (2009–2010 and 2011–2012, only). The ﬁrst and third ap-
proaches are both attempts to convert data from a spot sample to an
estimate of daily urinary excretion using a volume-based approach,
with information on the volume of urine excreted over a 24-h per-
iod. We might hypothesize that the NHANES-based data on urine
ﬂow rate would provide an improved estimate over generic litera-
ture-based 24-h urinary excretion or creatinine excretion values. To
test this assumption, we used the three approaches to estimate in-
takes using the 2009–2010 urinary BPA data. As shown in Fig. 2,
while for an individual, the approach used would potentially have a
large effect on the intake estimate, for the overall population, intakes
estimated with the three approaches are highly correlated.
Comparisons of generic 24-h urine excretion volumes (ICRP,
J.S. LaKind, D.Q. Naiman / Environmental Research 142 (2015) 84–95942002) and those derived from the NHANES data are shown in
Table 6. The mean NHANES-based 24-h urinary volumes are gen-
erally higher than the generic values for children and adults from
20–59 years of age. However, these differences do not result in
substantial changes to the distributions of daily intake of BPA.
The inconsistencies in associations between factors thought to be
associated with BPA exposure and BPA intakes - despite the high
correlations for intakes regardless of the method used to estimate
those intakes - demonstrates the difﬁculties in interpreting urinary
BPA data. Our results underscore the importance of continued re-
search on how to best utilize urinary measures of environmental
chemicals in exposure research in order to improve our ability to
interpret the data resulting from these studies. While it is outside
the scope of this paper to develop and offer a study design that
would resolve this issue, we believe that studies beyond the types
currently being conducted are needed to better understand the
implications of intra- and interindividual variability in creatinine
excretion (see, for example, Fortin et al., 2008) – as well as further
studies on the inﬂuence of generic versus measured urinary excre-
tion rates on interpretation of biomonitoring data. Until these types
of information are available, we recommend that biomonitoring
studies including urinary measures of environmental chemicals
provide results based on both adjusted and unadjusted approaches.
In summary, BPA exposures in the US have declined during the
time period from 2003 to 2012. Further, until a consensus is
achieved regarding the best biomonitoring approaches for asses-
sing exposures to short-lived chemicals using spot urine samples,
efforts to understand factors associated with BPA exposures
should include assessments using both volume-based and creati-
nine-adjusted urinary BPA levels and intake estimates.Acknowledgments
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